title: Dual antiplatelet therapy and the risk of bleeding.
authors.forename: Roy C
authors.initials: RC
authors.lastname: Ziegelstein
authors.forename: Ariel
authors.initials: A
authors.lastname: Green
authors.forename: Michael
authors.initials: M
authors.lastname: Sauder
mesh_terms: D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000150:complications; D000077144:Clopidogrel; D004359:Drug Therapy, Combination; D054855:Drug-Eluting Stents; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D018570:Risk Assessment; D012307:Risk Factors; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin